Abstract:e24145 Background: Breast cancer survivors with psychological problems have lower quality of life (QOL) and higher mortality than those without. It is important to monitor and manage their psychological status. The aim of this study was to examine the incidence and dynamic changes of anxiety/depression during postoperative adjuvant chemotherapy in Chinese breast cancer patients and to clarify the factors associated with anxiety/depression, the importance of family support, and the impact of anxiety/depression on QOL. Methods: In a prospective observational single-centre cohort study with early-stage breast cancer patients (n = 290), d epression and anxiety severity, QOL and social support were measured before chemotherapy, after 2 cycles of chemotherapy, and after the entire course of chemotherapy using the Hospital Anxiety and Depression Scale (HADS), Functional Assessment of Cancer Therapy-Breast Cancer (FACT-B) and Chinese version of the Social Support Rating Scale (SSRS), respectively. Canonical correlations were applied to identify correlates between anxiety/depression and demographic and clinical variables. Paired t tests were used to analyse dynamic changes in QOL. Relationships between anxiety/depression and QOL were analysed using two-way repeated measures analysis of covariance (RMANCOVA). Results: Throughout the entire course of chemotherapy, the incidences of anxiety and depression were 35.2% and 44.1%, respectively. 31.4% of the patients had an increased risk for an anxiety disorder before chemotherapy, which decreased to 29.0% after 2 cycles of chemotherapy and slightly increased to 29.3% after completion of chemotherapy. 20.0% of patients had an increased risk of depression before chemotherapy, which shifted to 25.2% and 24.8% after 2 cycles and the entire course of chemotherapy, respectively. Through multivariable analysis, age (p = 0.042), surgical method (p = 0.009), social support (p = 0.001) and breast cancer family history (p = 0.045) were significantly associated with depression. No variables were significantly associated with anxiety. Patients with higher HADS depression/anxiety scores had lower FACT-B scores during chemotherapy (p < 0.001). Conclusions: We observed dynamic changes in depression, anxiety and QOL throughout adjuvant chemotherapy and the associated factors of depression and anxiety. These findings provide guidance for psychological monitoring and support during postoperative chemotherapy of breast cancer patients. Clinical trial information: NCT05055375. [Table: see text]

Health-Related Quality of Life of Postmenopausal Chinese Women with Hormone Receptor-Positive Early Breast Cancer During Treatment with Adjuvant Aromatase Inhibitors: A Prospective, Multicenter, Non-Interventional Study

Incidence Of Menopausal Symptoms In Postmenopausal Breast Cancer Patients Treated With Aromatase Inhibitors

EFFECT OF ADJUVANT ENDOCRINE THERAPY ON ESTROGEN RECEPTOR-NEGATIVE, PROGESTERONE RECEPTOR-POSITIVE AND HER2 NEGATIVE BREAST CANCER PATIENTS

Impact of Menopausal Symptoms on Quality of Life 6 Months after Systemic Breast Cancer Treatment: Results from the Shanghai Breast Cancer Survival Study.

Quality of life and psychological functioning in postmenopausal women undergoing aromatase inhibitor treatment for early breast cancer

The Long-Term Impact of Medical and Socio-Demographic Factors on the Quality of Life of Breast Cancer Survivors Among Chinese Women

Acupoint Thread Embedding Combined With Wenshen Bugu Decoction for the Treatment of Aromatase Inhibitor-Associated Musculoskeletal Symptom Among Postmenopausal Breast Cancer Patients: Study Protocol of a Randomized Controlled Trial

Quality of Life (QoL) in Postmenopausal Breast Cancer Patients Receiving Adjuvant Hormonal Therapy

The Influence of Pharmaceutical Care in Patients with Breast Cancer Receiving Adjuvant Endocrine Therapy

Psychological symptoms and quality of life in Chinese early-stage breast cancer patients throughout chemotherapy.

Relationship of Lifestyle Habits to Health-Related Quality of Life of Recently Diagnosed Breast Cancer Between Younger and Older Women in China

Symptom Clusters and Quality of Life in Patients with Breast Cancer Receiving Endocrine Therapy in China.

Comprehensive nursing intervention in perimenopausal and postmenopausal women the effect of hormone replacement therapy

Relationship Between Menopause and Health-Related Quality of Life in Middle-Aged Chinese Women: a Cross-Sectional Study

Assessment of Quality of Life in Postmenopausal Women with Early Breast Cancer Participating in the PACT Trial: The Impact of Additional Patient Information Material Packages and Patient Compliance

[A prospective study of bone loss in early stage postmenopausal breast cancer treated with aromatase inhibitors]

Adherence and quality of life in women with breast cancer being treated with oral hormone therapy

Extended Adjuvant Therapy with Aromatase Inhibitors for Early Breast Cancer: A Meta-analysis of Randomized Controlled Trials.

Relationship between family support, serum lipid knowledge and quality of life in Chinese breast cancer women with adjuvant endocrine therapy

A Multicenter, Cross-Sectional Research of the Adherence to Endocrine Therapy with Selective Estrogen Receptor Modulators (serms) in Premenopausal Women in China.

Relationship Between Lifestyle Habits and Health-Related Quality of Life of Recently Diagnosed Breast Cancer Patients: A Comparison Between Younger and Older Women in China